Company / Net Income
Immunome Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$212.4M
FY2025
5-year range
-$212.4M / -$24.7M
FY2021-FY2025
Trend
-98.9%
vs FY2024
Sector context
#160 of 216
Health Care
What the data says
At -$212M, Immunome Inc.'s net income ranks #160 of 216 in the Health Care sector. Declined from -$37M to -$212M over the past 2 years.
Based on SEC 10-K filings.
-$212M in FY2025.
Declined from -$37M to -$212M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#160 of 216 in Health CareTop 74% of 216This company -$212.4M Sector average $454.1M
▼
-146.8% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 98.9% year-over-year.
- Ranks #160 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$212.4M | -98.9% |
| FY2024 | -$106.8M | -189.5% |
| FY2023 | -$36.9M | +0.0% |
| FY2022 | -$36.9M | -49.3% |
| FY2021 | -$24.7M | -38.5% |
| FY2020 | -$17.8M | -70.8% |
| FY2019 | -$10.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026